Trials / Completed
CompletedNCT04260373
Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers.
A Phase I Mass Balance and Biotransformation Study of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Study to Evaluate the Mass Balance and Biotransformation of Single Dose \[14C\]SHR4640 in Chinese healthy adult male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]SHR4640 | Patients will receive single dose of orally \[14C\]SHR4640 on Day 1. |
Timeline
- Start date
- 2020-03-19
- Primary completion
- 2020-04-03
- Completion
- 2020-04-03
- First posted
- 2020-02-07
- Last updated
- 2020-04-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04260373. Inclusion in this directory is not an endorsement.